Drug counselling in pregnancy: an opinion survey of French community pharmacists

Damase‐Michel, Christine; Vié, Céline; Lacroix, Isabelle; Lapeyre‐Mestre, Maryse; Jl, Montastruc

doi:10.1002/pds.954

Cited by 23 publications

(18 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It has been shown that CPs do not always give appropriate advice to pregnant women. 7 This could be explained by several points. First, initial training about drug use in pregnancy is insufficient during pharmaceutical and medical studies (2h within 6 years for CPs and 3.5h within 9 years for GPs).…”

Section: Discussionmentioning

confidence: 99%

Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area

Damase‐Michel

Pichereau

Pathak

et al. 2008

Pharmacy Practice (Internet)

Self Cite

View full text Add to dashboard Cite

*Counselling or prescribing drugs during pregnancy requires health professionals to assess risk/benefit ratio for women and their baby. A misperception of the risk may lead to inappropriate decisions for pregnancy outcomes. The aim of the present study was to assess teratogenic and/or foetotoxic risk perception of common medications by general practitioners (GPs) and community pharmacists (CPs) from the MidiPyrenees area. Methods: 103 GPs and 104 CPs were interviewed. For 21 given drugs, a visual-analogue scale was used to evaluate the risk to give birth to a malformed infant if the mother had taken the drug during first trimester of pregnancy. For 9 drugs, health professionals had to say if they thought there was a potential foetotoxic and/or neonatal risk when drugs were administered during late pregnancy. Results: 97% and 91% of GPs and CPs respectively thought that isotretinoin and thalidomide are teratogenic and more than 80% thought that amoxicillin and acetaminophen are safe in early pregnancy. However, 19% of the GPs and 33% of CPs answered there were no teratogenic risk for valproate. Around 11% of both GPs and CPs said that warfarin was safe during pregnancy. For 22% of GPs and for 13% and 27% of CPs respectively, ibuprofen and enalapril were safe on late pregnancy. For each drug, mean value of perceived teratogenic risk by health professionals was higher than values that can be found in scientific references. Concerning isotretinoin, thalidomide and metoclopramide, perceived teratogenic risk was higher for CPs. PERCEPCIÓN DEL RIESGO TERATOGÉNICO Y FETOTÓXICO POR LOS PROFESIONALES DE LA SALUD: ESTUDIO EN EL AREA DE MIDI-PYRENEES RESUMENAconsejar o prescribir medicamentos durante el embarazo requiere que los profesionales de la salud evalúen la relación riesgo/beneficio para la mujer y su bebé. Una mala percepción del riesgo, puede llevar a decisiones inapropiadas para los resultados del embarazo. El objetivo del presente estudio fue evaluar la percepción del riesgo teratogénico y/o fetotóxico de medicamentos frecuentes por médicos generales (MG) y farmacéuticos comunitarios (FC) de la región de Midi-Pyrenees. Métodos: Se entrevistó a 103 MG y 104 FC. Se utilizó una escala visual analógica EVA para evaluar el riesgo de dar a luz un niño malformado si la madre había usado el medicamento durante el primer trimestre de embarazo. Para 9 medicamentos, los profesionales tenían que decir si pensaban que había un riesgo teratogéncio y/o fetotóxico cuando se administraban los medicamentos al final del embarazo. Resultados: el 97% y el 91% de los MG y FC respectivamente pensaron que la isotretinoína y la talidomida eran teratogénicos y más del 80% pensó que la amoxicilina y el paracetamol eran seguros al principio del embarazo. Sin embargo, el 19% de los MG y el 33 de los FC respondió que no había riesgo teratogénico en el valproato. Cerca del 11% tanto de MG y de FC dijo que la warfarina era segura durante el embarazo. Para el 22% de los MG y para 13% y 27% de FC el ibuprofeno y el enalaprilo eran segu...

show abstract

Section: Discussionmentioning

confidence: 99%

Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area

Damase‐Michel

Pichereau

Pathak

et al. 2008

Pharmacy Practice (Internet)

Self Cite

View full text Add to dashboard Cite

show abstract

“…As shown in Table 3, all studies were descriptive and cross-sectional with samples of 110-276 pharmacists, mainly practicing in community pharmacies. Three out of four studies presented various scenarios to pharmacists and questioned them about their counselling on pharmacological as well as non-pharmacological treatment, and referral to a physician [49][50][51].…”

Section: Community Pharmacists' Counselling Of Pregnant Womenmentioning

confidence: 99%

Women’s Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists

Ceulemans

Lupattelli

Nordeng

et al. 2019

CPD

View full text Add to dashboard Cite

BackgroundDuring pregnancy women might weigh benefits of treatment against potential risks to the unborn child. However, non-adherence to necessary treatment can adversely affect both mother and child. To optimize pregnant women's beliefs and medication adherence, community pharmacists are ideally positioned to play an important role in primary care. ObjectiveThis narrative review aimed to summarize the evidence on 1) pregnant women's beliefs, 2) medication adherence in pregnancy, and 3) community pharmacists' counselling during pregnancy. MethodThree search strategies were used in Medline and Embase to find original studies evaluating women's beliefs, medication adherence and community pharmacists' counselling during pregnancy. All original descriptive and analytic epidemiological studies performed in Europe, North America and Australia, written in English and published from 2000 onwards were included. ResultsWe included 14 studies reporting on women's beliefs, 11 studies on medication adherence and 9 on community pharmacists' counselling during pregnancy. Women are more reluctant to use medicines during pregnancy and tend to overestimate the teratogenic risk of medicines. Risk perception varies with type of medicine, level of health literacy, education level and occupation. Furthermore, low medication adherence during pregnancy is common. Finally, limited evidence showed current community pharmacists' counselling is insufficient. Barriers hindering pharmacists are insufficient knowledge and limited access to reliable information. ConclusionConcerns about medication use and non-adherence are widespread among pregnant women. Community pharmacists' counselling during pregnancy is insufficient. Further education, training and research are required to support community pharmacists in fulfilling all the opportunities they have when counselling pregnant women.

show abstract

“…However, very few studies have investigated pharmacists' counselling of pregnant women (Appendix 1). The findings showed that pharmacists did not always give appropriate information to pregnant women (Schrempp et al, 2001;Lyszkiewicz et al, 2001;Damase-Michel et al, 2004). They often referred women to a physician or recommended homeopathy (Lyszkiewicz et al, 2001;Damase-Michel et al, 2004).…”

Section: Introductionmentioning

confidence: 93%

“…Pharmacists felt uncertain if disagreeing with the physician and they needed additional education ( (Schrempp et al, 2001;Lyszkiewicz et al, 2001;Damase-Michel et al, 2004;Grincevičiene et al, 2015;Bains at el., 2014). In spite of such findings, the International Pharmaceutical Federation (FIP) proposed a policy statement in 2013 which declares certain interventions where pharmacists can make a significant contribution in improvement of maternal health.…”

Section: Introductionmentioning

confidence: 97%

Pharmacists counselling of pregnant women: Web-based, comparative study between Serbia and Norway

et al. 2016

View full text Add to dashboard Cite

Drug counselling in pregnancy: an opinion survey of French community pharmacists

Abstract: The present study shows that French community pharmacists do not always give appropriate advice to pregnant women. As primary health care providers, pharmacists have to improve counselling regarding drug use in pregnancy.

Cited by 23 publications

References 8 publications

Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area

Perception of teratogenic and foetotoxic risk by health professionals: a survey in Midi-Pyrenees area

Women’s Beliefs About Medicines and Adherence to Pharmacotherapy in Pregnancy: Opportunities for Community Pharmacists

Pharmacists counselling of pregnant women: Web-based, comparative study between Serbia and Norway

Contact Info

Product

Resources

About